Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

PREDICT Offers a Heads-up on the Need for CT in Suspected Small Aortic Annuli

News Conference News EuroPCR 2025

PREDICT Offers a Heads-up on the Need for CT in Suspected Small Aortic Annuli

May 23, 2025

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

News Conference News EuroPCR 2024

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

May 24, 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

May 16, 2024

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

May 19, 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

News Conference News EuroPCR 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

May 16, 2023

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

May 18, 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

May 17, 2022

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

News Conference News EuroPCR 2020

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Yael L. Maxwell

July 01, 2020

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

June 07, 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

May 31, 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

May 16, 2019

Pace Quickens for Mitral Device Innovation for Repair, Replacement

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

May 23, 2018

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

May 17, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.